Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced its inclusion in Forbes' "World's Best Management Consulting Firms ...

Analyst Bryan Keane of Deutsche Bank maintained a Hold rating on Genpact (G – Research Report), retaining the price target of $37.00. Bryan Keane’s rating is based on the comprehensive ...

The buyout will enable Genpact to leverage on Barkawi Management Consultants' consulting expertise and supply chain technology services for creating global, end-to-end supply chain services ...

Genpact (G – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Bryan Bergin from TD Cowen maintained a Hold rating on the stock and has a ...

Let’s take a look at how Genpact (NYSE:G) and the rest of the business process outsourcing & consulting stocks fared in Q1.

Other Driving Factors Genpact's domain expertise in business analytics, digital and consulting sectors is a key catalyst for growth.

Genpact Pharmalink Global Regulatory Affairs combines Pharmalink's specialized domain expertise in consulting, project support and outsourced regulatory affairs services with Genpact's global ...

Aiming to enhance its domain knowledge and expertise in life sciences, BPO services major Genpact plans to acquire Pharmalink Consulting, a global provider of regulatory services in life sciences ...

Genpact plans to acquire Pharmalink Consulting, a global provider of regulatory services in life sciences, for an undisclosed amount.

Recognition underscores Genpact's end-to-end capabilities and sustained success in creating value for clients by driving real-world transformation NEW YORK, Sept. 15, 2022 /PRNewswire/ -- Genpact ...

Genpact G holds a prominent position in the BPO services market, leveraging expertise in business analytics, digital and consulting services. The company recognizes a substantial growth ...